Advances in immunotherapy for triple-negative breast cancer

Y Liu, Y Hu, J Xue, J Li, J Yi, J Bu, Z Zhang, P Qiu… - Molecular cancer, 2023 - Springer
Background Immunotherapy has recently emerged as a treatment strategy which stimulates
the human immune system to kill tumor cells. Tumor immunotherapy is based on immune …

[HTML][HTML] Fusobacterium nucleatum and colorectal cancer: A review

FM Shang, HL Liu - World journal of gastrointestinal oncology, 2018 - ncbi.nlm.nih.gov
Fusobacterium nucleatum (F. nucleatum) is a Gram-negative obligate anaerobe bacterium
in the oral cavity and plays a role in several oral diseases, including periodontitis and …

Natural and therapy-induced immunosurveillance in breast cancer

G Kroemer, L Senovilla, L Galluzzi, F André… - Nature medicine, 2015 - nature.com
The immunosurveillance theory postulates that tumors evolve and progress in an
uncontrolled fashion only when anticancer immune responses fail. Natural …

The characteristics of tumor microenvironment in triple negative breast cancer

Y Fan, S He - Cancer Management and Research, 2022 - Taylor & Francis
Triple-negative breast cancer (TNBC) is a special subtype of breast cancer, accounting for
10–20% of breast cancers with high intrinsic heterogeneity. Its unique immune …

Selenium nanoparticles regulates selenoprotein to boost cytokine-induced killer cells-based cancer immunotherapy

T Liu, L Xu, L He, J Zhao, Z Zhang, Q Chen, T Chen - Nano Today, 2020 - Elsevier
As one of the typical adoptive cell transfer modality, cytokine-induced killer cell (CIK)-
mediated immunotherapy exhibits promising applications in cancer treatment. However, the …

Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity

O Bakos, C Lawson, S Rouleau, LH Tai - Journal for immunotherapy of …, 2018 - Springer
Background Cancer surgery is necessary and life-saving. However, the majority of patients
develop postoperative recurrence and metastasis, which are the main causes of cancer …

Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects

H Jia, CI Truica, B Wang, Y Wang, X Ren… - Drug resistance …, 2017 - Elsevier
Patients with breast tumors that do not express the estrogen receptor, the progesterone
receptor, nor Her-2/neu are hence termed “triple negatives”, and generally have a poor …

Immunotherapeutic interventions of triple negative breast cancer

Z Li, Y Qiu, W Lu, Y Jiang, J Wang - Journal of translational medicine, 2018 - Springer
Abstract Triple Negative Breast Cancer (TNBC) is a highly heterogeneous subtype of breast
cancer that lacks the expression of oestrogen receptors, progesterone receptors and human …

Recent advances in nanotheranostics for triple negative breast cancer treatment

V Thakur, RV Kutty - Journal of Experimental & Clinical Cancer Research, 2019 - Springer
Triple-negative breast cancer (TNBC) is the most complex and aggressive type of breast
cancer encountered world widely in women. Absence of hormonal receptors on breast …

Resolution of cancer-promoting inflammation: a new approach for anticancer therapy

Q Zhang, B Zhu, Y Li - Frontiers in immunology, 2017 - frontiersin.org
Inflammation is a protective response that eliminates harmful stimuli and restores tissue
homeostasis, whereas the failure to resolve inflammation leads to the development of …